Diagnostic Testing of STDs Market, By Test Type (Chlamydia, Gonorrhea, Syphilis, HIV, HPV+pap smear, HSV, and Chancroid), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jun 2023

Code : CMI3917

Pages :160

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Regional Analysis

Global Diagnostic Testing of STDs Market - Regional Analysis

Among region, North America is estimated to hold a dominant position in the global diagnostic testing of STDs market over the forecast period owing to increasing product launches. For instance, Bio-Rad Laboratories, Inc., a U.S.-based manufacturer of life science technology, entered into a partnership with Seegene Inc., a South Korea-based diagnostic products manufacturer for the development and commercialization of infectious disease molecular diagnostic products. Under the terms of the agreement, Seegene Inc. will provide diagnostic tests for use on Bio-Rad’s CFX96 Dx Real-Time PCR System for the U.S. market.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa